School of Pharmaceutical Sciences, College of Medical, Pharmaceutical and Health Sciences , Kanazawa University , Kanazawa , 920-1192 , Japan.
Chemical Biology and Medicinal Chemistry, Eshelman School of Pharmacy , University of North Carolina , Chapel Hill , North Carolina 27599-7568 , United States.
J Org Chem. 2019 Mar 15;84(6):3239-3248. doi: 10.1021/acs.joc.8b02832. Epub 2019 Mar 5.
The first syntheses of 4- epi-parviflorons A, C, and E (4- epi-1-3) were achieved in 12-13 steps from commercially available (-)-abietic acid (5). All synthesized compounds, including intermediates and derivatives, were evaluated for antiproliferative activity against five human tumor cell lines. A structure-activity relationship study revealed no significant difference between Pf E and 4- epi-Pf E, the importance of two oxygen functional groups at C-11 and C-12 for antiproliferative activity, as well as a combination of carbomethoxy at C-4 and a benzoyl ester with electron-drawing group at C-12 or hydroxymethyl at C-4 and an appropriate oxidation state of ring-B/C for triple-negative breast cancer cell selectivity.
首次从商业可得的 (-)-松香酸 (5) 经 12-13 步反应合成了 4-表-对映贝壳杉烯 A、C 和 E (4-表-1-3)。所有合成的化合物,包括中间体和衍生物,都评估了对五种人肿瘤细胞系的抗增殖活性。构效关系研究表明,Pf E 和 4-表-Pf E 之间没有显著差异,C-11 和 C-12 上的两个含氧官能团对抗增殖活性很重要,C-4 上的甲氧基羰基和 C-12 上的吸电子基团或 C-4 上的羟甲基以及环-B/C 的适当氧化态对于三阴性乳腺癌细胞的选择性很重要。